CRISPR Therapeutics AG — Form D

CRISPR Therapeutics AG of Zug, V6, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-04. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ali Anthony BehbahaniDirectorBasel, V8
Bradley Anthony BolzonDirectorBasel, V8
Pablo J CagnoniDirectorBasel, V8
N. Anthony ColesDirectorBoston, MA
Simeon J GeorgeDirectorWayne, PA
Kurt J von EmsterDirectorBasel, V8
Thomas J WoiwodeDirectorSan Francisco, CA
Marc J BeckerExecutive OfficerCambridge, MA
Tyler Ante Dylan-HydeExecutive OfficerCambridge, MA
Samarth Ante KulkarniExecutive OfficerCambridge, MA
Sven Ante LundbergExecutive OfficerCambridge, MA
Kala Ante SubramanianExecutive OfficerCambridge, MA
Simeon GeorgeDirectorRedwood City, CA
Ali BehbahaniDirectorLittleton, CO
Tony HoExecutive OfficerCharlestown, MA
Bradley BolzonDirectorSAN DIEGO, CA
John GreeneDirectorScottsdale, AZ
Lawrence KleinExecutive OfficerZug, V8
Rodger NovakDirectorZug, V8
Rodger NovakExecutive OfficerZug, V8
Samarth KulkarniDirectorZug, V8
Samarth KulkarniExecutive OfficerZug, V8
James KasingerExecutive OfficerZug, V8
Katherine HighDirectorZug, V8
Michael TomsicekExecutive OfficerZug, V8

Other filings by this issuer (2)

FiledFormOfferingSold
2020-04-10D/A$1.0M$1.0M
2020-04-09D$1.0M$1.0M

More